Arrowhead Pharmaceuticals Inc Reports Fiscal Q1 2024 Results with Strategic Focus on ... [Yahoo! Finance]
Arrowhead Pharmaceuticals, Inc. (ARWR)
Last arrowhead pharmaceuticals, inc. earnings: 2/5 04:00 pm
Check Earnings Report
US:NASDAQ Investor Relations:
ir.arrowheadpharma.com/investor-relations
Company Research
Source: Yahoo! Finance
Operating Loss: The company experienced an operating loss of $136.55 million, a substantial increase from the $42.13 million loss reported in Q1 2023. Net Loss: Net loss attributable to ARWR was $132.86 million, or $1.24 per diluted share, compared to a net loss of $41.33 million, or $0.39 per diluted share, in the prior year. Balance Sheet: Total assets decreased to $626.29 million, down from $765.55 million at the end of the previous fiscal year. Cash Position: Cash, cash equivalents, and investments totaled $220.28 million, a decrease from $403.63 million as of September 30, 2023. R&D and Corporate Restructuring: ARWR is focusing on late-stage clinical development and commercial infrastructure, particularly in cardiometabolic and pulmonary areas, and has restructured its R&D organization to optimize resources. Stock Offering: The company strengthened its balance sheet with a $450 million common stock offering, before expenses. Warning! GuruFocus has detected 4 Warning
Show less
Read more
Impact Snapshot
Event Time:
ARWR
Last Price
Price Change
Price Change%
Volume Shares
Max Up
Max Down
%
Volume Ratio
Performance Comparison
Updated
|
Event Day
Stock performance from the time of news release until the following 4pm ET market close
|
Last price at news event
|
Since Event
Multi-day stock performance from the time of the news release
|
|---|---|---|
|
EVENT DAY
Stock performance from the time of news release until the following 4pm ET market close
|
LAST
PRICE AT NEWS EVENT |
SINCE EVENT
Multi-day stock performance from the time of the news release
|
| Last Price | ||
| VWAP | ||
|
High:
|
Max Up |
High:
|
|
Low:
|
Max Down |
Low:
|
|
%
|
Post news range |
%
|
|
|
Price change |
|
|
|
Price Change Percentage |
|
|
|
S&P 500 (SPX) |
|
|
%
|
Volume ratio |
%
|
| Volume | ||
| Ticks | ||
|
|
Avg transaction size |
|
Don't Miss Out On The Next BIG Stock Move
Event day
Event Day Chart will not be displayed beyond 90-day period of the event
Performance since event
Time And Velocity Analysis
Be the first to know
Opt in for alerts from News Quantifed
Sign Up Today
Opt-in for
ARWR alerts
Learn More With NQ
Reading the Impact Report
Help Me Understand This Data
Help Me Understand This Data
How NQ Works
What is news-based trading?
And why is it so successful?
And why is it so successful?
Movers & Shakers
The biggest gainers and losers and WHY it moved
ARWR alerts
High impacting Arrowhead Pharmaceuticals, Inc. news events
Weekly update
A roundup of the hottest topics
ARWR
News
- Arrowhead Pharmaceuticals Earns $50 Million Milestone from Royalty PharmaBusiness Wire
- Arrowhead Pharmaceuticals to Participate in Upcoming May 2024 Conferences [Yahoo! Finance]Yahoo! Finance
- Arrowhead Pharmaceuticals to Participate in Upcoming May 2024 ConferencesBusiness Wire
- Arrowhead Pharmaceuticals to Host 2024 Summer Series of R&D WebinarsBusiness Wire
- Arrowhead Pharmaceuticals to Webcast Fiscal 2024 Second Quarter ResultsBusiness Wire
ARWR
Earnings
- 8/7/23 - Miss
ARWR
Sec Filings
- 5/2/24 - Form 144
- 4/10/24 - Form SC
- 4/3/24 - Form 4
- ARWR's page on the SEC website